Sickle Cell Trait and its Increased Risk for Venous Thromboembolism

Thursday, 12 September 2024, 21:27

Individuals with sickle cell trait (SCT) face an increased risk for venous thromboembolism (VTE), new research reveals. Understanding this link is crucial for effective patient management. This finding, published in Blood Advances, highlights the need for awareness and further studies.
LivaRava_Medicine_Default.png
Sickle Cell Trait and its Increased Risk for Venous Thromboembolism

Understanding Sickle Cell Trait and Venous Thromboembolism

Recent research has shown that individuals with sickle cell trait (SCT) are at a heightened risk for venous thromboembolism (VTE). The study, conducted by Keng-Han Lin, Ph.D., from 23andMe, and published online on September 12 in Blood Advances, examines this critical correlation.

Key Findings

  • Sickle cell trait (SCT) may lead to changes in blood flow.
  • There is a significant association between SCT and VTE.
  • Increased awareness among healthcare providers is essential.

Importance for Patients

Patients with SCT should be informed about their potential increased risk for venous thromboembolism. Regular check-ups and discussions regarding personal risk factors are advisable.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe